The latest international Bayer AG news and views from Reuters - one of the world's largest news agencies ...

Bayer has its first regulatory approval for elinzanetant as a non-hormonal treatment for menopausal symptoms – in the UK – as it chases down a rival therapy from Astellas.

Lilly is on track to file its oral GLP-1 agonist orforglipron for type 2 diabetes next year after presenting the first phase 3 data with the drug.

NovoLog is a prescription drug used to treat diabetes. Learn about the drug’s dosages, forms, strength, and more.